| For: | Gunduz H, Karabay O, Tamer A, Özaras R, Mert A, Tabak &F. N-acetyl cysteine therapy in acute viral hepatitis. World J Gastroenterol 2003; 9(12): 2698-2700 [PMID: 14669316 DOI: 10.3748/wjg.v9.i12.2698] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i12/2698.htm |
| Number | Citing Articles |
| 1 |
J. Wiegand, H. Wedemeyer, A. Franke, S. Rößler, S. Zeuzem, G. Teuber, M. Wächtler, U. Römmele, B. Ruf, U. Spengler, C. Trautwein, C. T. Bock, G. M. Fiedler, J. Thiery, M. P. Manns, O. Brosteanu, H. L. Tillmann. Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double‐blinded multicentre trial. Journal of Viral Hepatitis 2014; 21(10) doi: 10.1111/jvh.12210
|
| 2 |
Ameer Abutaleb, Shyam Kottilil. Hepatitis A. Gastroenterology Clinics of North America 2020; 49(2) doi: 10.1016/j.gtc.2020.01.002
|
| 3 |
Ji-Hoon Park, Kang-Sik Seo, Surendar Tadi, Bong-Hyun Ahn, Jung-Uee Lee, Jun-Young Heo, Jeongsu Han, Myoung-Sub Song, Soon-Ha Kim, Yong-Hyeon Yim, Hueng-Sik Choi, Minho Shong, GiRyang Kweon.
An Indole Derivative Protects Against Acetaminophen-Induced Liver Injury by Directly Binding to
N
-Acetyl-
p
-Benzoquinone Imine in Mice
. Antioxidants & Redox Signaling 2013; 18(14) doi: 10.1089/ars.2012.4677
|
| 4 |
R. Bruno, G. Carosi, N. Coppola, G. B. Gaeta, M. Puoti, T. Santantonio, G. Taliani, O. Armignacco, E. Sagnelli, M. Andreoni, G. Angarano, G. Di Perri, G. D’Offizi, M. Galli, G. Rizzardini. Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT). Infection 2014; 42(5) doi: 10.1007/s15010-014-0642-0
|
| 5 |
Muthusamy Sureshan, Sathishkumar Brintha, Arunachalam Jothi. Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3Cpro and RdRP enzymes through structure-based virtual screening, dynamics simulation, and DFT studies. Molecular Diversity 2024; 28(3) doi: 10.1007/s11030-023-10679-7
|
| 6 |
Mihai Popescu, Angelica Bratu, Mihaela Agapie, Tudor Borjog, Mugurel Jafal, Romina-Marina Sima, Carmen Orban. The Use and Potential Benefits of N-Acetylcysteine in Non-Acetaminophen Acute Liver Failure: An Etiology-Based Review. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030676
|
| 7 |
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman. Therapeutic Advances in Viral Hepatitis A–E. Advances in Therapy 2022; 39(4) doi: 10.1007/s12325-022-02070-z
|
| 8 |
Kenneth E. Sherman, Shyam Kottilil. Schiff's Diseases of the Liver. 2017; doi: 10.1002/9781119251316.ch23
|
| 9 |
Samar K. Darweesh, Mona F. Ibrahim, Mahmoud A. El-Tahawy. Effect of N-Acetylcysteine on Mortality and Liver Transplantation Rate in Non-Acetaminophen-Induced Acute Liver Failure: A Multicenter Study. Clinical Drug Investigation 2017; 37(5) doi: 10.1007/s40261-017-0505-4
|
| 10 |
|
| 11 |
Filippo Gabrielli, Francesco Alberti, Cristina Russo, Carmela Cursaro, Hajrie Seferi, Marzia Margotti, Pietro Andreone. Treatment Options for Hepatitis A and E: A Non-Systematic Review. Viruses 2023; 15(5) doi: 10.3390/v15051080
|
| 12 |
Pietro Torre, Andrea Aglitti, Mario Masarone, Marcello Persico. Viral hepatitis: Milestones, unresolved issues, and future goals. World Journal of Gastroenterology 2021; 27(28): 4603-4638 doi: 10.3748/wjg.v27.i28.4603
|
| 13 |
Waleed Aljohani, Brian Pak Ho Chan, Mohammad Yaghoobi. Role ofN-Acetylcysteine in the Treatment of Acute Nonacetaminophen, Nonalcoholic and Nonviral Hepatitis: A Meta-analysis. Journal of the Canadian Association of Gastroenterology 2021; 4(3) doi: 10.1093/jcag/gwaa017
|
| 14 |
S. Yu. Chikina. Fluimucil and recent clinical practice. PULMONOLOGIYA 2005; (4) doi: 10.18093/0869-0189-2005-0-4-97-111
|
| 15 |
Vinod V. S, Vijithkumar K, Riyas C, Malini V. S, Arun S. Menon. A Study on the Role of N-Acetyl Cysteine Therapy in Acute Viral Hepatitis A. Journal of Evidence Based Medicine and Healthcare 2020; 7(22) doi: 10.18410/jebmh/2020/231
|
| 16 |
Kamolwish Laoprasopwattana, Puttichart Khantee, Kantara Saelim, Alan Geater. Mortality Rates of Severe Dengue Viral Infection Before and After Implementation of a Revised Guideline for Severe Dengue. Pediatric Infectious Disease Journal 2022; 41(3) doi: 10.1097/INF.0000000000003411
|
| 17 |
Hans L. Tillmann, Kalliopi Zachou, George N. Dalekos. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?. Liver International 2012; 32(4) doi: 10.1111/j.1478-3231.2011.02682.x
|
| 18 |
Yong Sun, Li-Yong Pu, Ling Lu, Xue-Hao Wang, Feng Zhang, Jian-Hua Rao. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury. World Journal of Gastroenterology 2014; 20(41): 15289-15298 doi: 10.3748/wjg.v20.i41.15289
|
| 19 |
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno, Clarissa Berardo. Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants 2021; 10(3) doi: 10.3390/antiox10030364
|
| 20 |
László Galgóczy, Laura Kovács, Krisztina Krizsán, Tamás Papp, Csaba Vágvölgyi. Inhibitory Effects of Cysteine and Cysteine Derivatives on Germination of Sporangiospores and Hyphal Growth of Different Zygomycetes. Mycopathologia 2009; 168(3) doi: 10.1007/s11046-009-9204-x
|
| 21 |
Najmolsadat Atefi, Elham Behrangi, Samaneh Mozafarpoor, Farnoosh Seirafianpour, Shadi Peighambari, Azadeh Goodarzi. N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study. Journal of Research in Medical Sciences 2020; 25(1) doi: 10.4103/jrms.JRMS_777_20
|
| 22 |
Jacky TP Siu, Trina Nguyen, Ricky D Turgeon. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure. Cochrane Database of Systematic Reviews 2020; 2020(12) doi: 10.1002/14651858.CD012123.pub2
|